NCT05322577
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05322577
Title A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. (FORTITUDE-103)
Acronym FORTITUDE-103
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Northport Veterans Affairs Medical Center Northport New York 11768 United States Details
Fujita Health University Hospital Toyoake-shi Aichi-ken 470-1192 Japan Details
Hirosaki University Hospital Hirosaki-shi Aomori 036-8563 Japan Details
Chiba University Hospital Chiba Chiba 260-8677 Japan Details
National Hospital Organization Shikoku Cancer Center Matsuyama Ehime 791-0280 Japan Details
Fukui Prefectural Hospital Fukui-shi Fukui 910-8526 Japan Details
Kyushu University Hospital Fukuoka Fukuoka 812-8582 Japan Details
Fukushima Medical University Hospital Fukushima Fukushima 960-1295 Japan Details
Gifu University Hospital Gifu Gifu 501-1194 Japan Details
Ogaki Municipal Hospital Ogaki-shi Gifu 503-8502 Japan Details
Gunma University Hospital Maebashi Gunma 371-8511 Japan Details
Gunma Prefectural Cancer Center Ota-shi Gunma 373-8550 Japan Details
Hiroshima City Hiroshima Citizens Hospital Hiroshima Hiroshima 730-8518 Japan Details
Hiroshima University Hospital Hiroshima Hiroshima 734-8551 Japan Details
Ibaraki Prefectural Central Hospital Kasama-shi Ibaraki 309-1793 Japan Details
Ishikawa Prefectural Central Hospital Kanazawa Ishikawa-ken 920-8530 Japan Details
Kagawa University Hospital Kita-gun Kagawa-ken 761-0793 Japan Details
St Marianna University Hospital Kawasaki-shi Kanagawa 216-8511 Japan Details
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center Yokohama Kanagawa 241-8515 Japan Details
Kochi Health Sciences Center Kochi Kochi 781-8555 Japan Details
Kyoto University Hospital Kyoto Kyoto 606-8507 Japan Details
Tohoku University Hospital Sendai Miyagi 980-8574 Japan Details
Okayama University Hospital Okayama Okayama-ken 700-8558 Japan Details
Osaka General Medical Center Osaka Osaka 558-8558 Japan Details
Osaka Medical and Pharmaceutical University Hospital Takatsuki-shi Osaka 569-8686 Japan Details
Shizuoka General Hospital Shizuoka Shizuoka 420-8527 Japan Details
Shizuoka Cancer Center Sunto-gun Shizuoka 411-8777 Japan Details
Dokkyo Medical University Hospital Shimotsuga-gun Tochigi 321-0293 Japan Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
The Cancer Institute Hospital of Japanese Foundation for Cancer Research Koto-ku Tokyo 135-8550 Japan Details
IMSUT Hospital, The Institute of Medical Science The University of Tokyo Minato-ku Tokyo 108-8639 Japan Details
Toyama University Hospital Toyama Toyama 930-0194 Japan Details
National University Hospital Singapore 119074 Singapore Details
National Cancer Center Goyang-si Gyeonggi-do 10408 South Korea Details
Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do 13620 South Korea Details
Seoul National University Hospital Seoul 03080 South Korea Details
Severance Hospital Yonsei University Health System Seoul 03722 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Korea University Guro Hospital Seoul 08308 South Korea Details
National Taiwan University Hospital Taipei 10002 Taiwan Details
Taipei Veterans General Hospital Taipei 11217 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field